No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹75.21Prev. Close
₹75.82Turnover(Lac.)
₹44.37Day's High
₹76.37Day's Low
₹73.152 Week's High
₹114.952 Week's Low
₹74Book Value
₹34.12Face Value
₹5Mkt Cap (₹ Cr.)
740.45P/E
19.1EPS
3.86Divi. Yield
1.0223 May 2025
12:00 AM
AGM
Announcement Date: 23 May, 2025
9 Jul 2025
12:00 AM
Bonus
23 May 2025
12:00 AM
BookCloser
31 Oct 2025
12:00 AM
Board Meeting
Agenda : Audited Result
23 May 2025
12:00 AM
Dividend
Dividend Amount: 1.5
Record Date: 15 Aug, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 25.06 | 25.06 | 25.06 | 25.06 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 300.97 | 266.16 | 216.17 | 188.72 |
Net Worth | 326.03 | 291.22 | 241.23 | 213.78 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 431.96 | 306.95 | 238.07 | 206.14 |
yoy growth (%) | 40.72 | 28.93 | 15.48 | -36.8 |
Raw materials | -329.79 | -230.16 | -180.79 | -150.61 |
As % of sales | 76.34 | 74.98 | 75.93 | 73.06 |
Employee costs | -14.29 | -13.36 | -9 | -7.21 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 38.55 | 19.15 | 23.41 | 27.58 |
Depreciation | -15.07 | -7.03 | -1.83 | -1.96 |
Tax paid | -10.11 | -4.85 | -6.9 | -7.53 |
Working capital | 61.47 | -22.96 | 11.14 | -7.43 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 40.72 | 28.93 | 15.48 | -36.8 |
Op profit growth | 95.81 | 27.2 | -18.66 | -40.08 |
EBIT growth | 100.75 | -14.96 | -15.1 | -27.25 |
Net profit growth | 98.78 | -13.36 | -17.64 | -22.29 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,668.9 | 85.69 | 4,00,496.99 | 564.22 | 0.96 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,236 | 65.83 | 1,65,491.79 | 696 | 0.48 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,018.2 | 63.73 | 1,36,012.76 | 597 | 0.15 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,397.5 | 21.72 | 1,12,922.38 | 1,210.53 | 1.14 | 4,495.16 | 411.56 |
Lupin Ltd LUPIN | 2,177.9 | 18.63 | 99,410.84 | 1,357.35 | 0.55 | 3,852.79 | 595.98 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Arun Todarwal
Vice Chairman (Non-executive)
Bipin N Shah
Joint MD & Executive Director
Ritesh B Shah
Joint MD & Executive Director
Vivek B Shah
Non Executive Director
Bharat N Shah
Non Executive Director
Samir J Shah
Non Executive Director
Ketan L Shah
Non Executive Director
Gaurav Shah
Independent Non Exe. Director
Harmanbhai Tulsibhai Patel
Independent Non Exe. Director
Mita Dixit
Independent Director
Siddharth Shah
Independent Director
Pradeep Thakur
Company Sec. & Compli. Officer
Manan Jayesh Vadhan
3-A Shivsagar Estate,
North Wing Dr A B Road Worli,
Maharashtra - 400018
Tel: 91-22-6622 7575
Website: http://www.anuhpharma.com
Email: anuh@sk1932.com
J/12 Ansa Indl Est,
Sakivihar Road, Sakinaka Andheri (E),
Mumbai - 400072
Tel: 91-22-8524914/852354
Website: www.bigshareonline.com
Email: marketing@bigshareonline.com
Summary
Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Th...
Read More
Reports by Anuh Pharma Ltd
What is the Anuh Pharma Ltd share price today?
What is the Market Cap of Anuh Pharma Ltd?
What is the PE and PB ratio of Anuh Pharma Ltd?
What is the 52 Week High and Low of Anuh Pharma Ltd?
What is the CAGR of Anuh Pharma Ltd?
What is the shareholding pattern of Anuh Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
